Shudong Wang

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 17

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of medicinal chemistry

Pharmaceutical patent analyst

This page only lists publications with an associated author ORCID identifier.

Publications

Biruk Sintayehu Fanta, Jimma Lenjisa, Theodosia Teo, Lianmeng Kou, Laychiluh B Mekonnen, Yuchao Yang, Sunita K C Basnet, Ramin Hassankhani, Matthew J Sykes, Mingfeng Yu, Shudong Wang
Discovery of N ,4-Di(1 H -pyrazol-4-yl)pyrimidin-2-amine-Derived CDK2 Inhibitors as Potential Anticancer Agents: Design, Synthesis, and Evaluation. Molecules (Basel, Switzerland) 28 (7) (2023)
Saiful Islam, Muhammed H Rahaman, Mingfeng Yu, Benjamin Noll, Jennifer H Martin, Shudong Wang, Richard Head
Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition. Cancers 15 (4) (2023)
Saiful Islam, Muhammed H Rahaman, Mingfeng Yu, Benjamin Noll, Jennifer H Martin, Shudong Wang, Richard Head
Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition. Cancers 15 (4) (2023)
Saiful Islam, Muhammed H Rahaman, Mingfeng Yu, Benjamin Noll, Jennifer H Martin, Shudong Wang, Richard Head
Anti-Leukaemic Activity of Rilpivirine Is Mediated by Aurora A Kinase Inhibition. Cancers 15 (4) (2023)
Saiful Islam, Theodosia Teo, Malika Kumarasiri, Martin Slater, Jennifer H Martin, Shudong Wang, Richard Head
Combined In Silico and In Vitro Evidence Supporting an Aurora A Kinase Inhibitory Role of the Anti-Viral Drug Rilpivirine and an Anti-Proliferative Influence on Cancer Cells. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Renjie Chen, Ramin Hassankhani, Yi Long, Sunita K C Basnet, Theodosia Teo, Yuchao Yang, Laychiluh Mekonnen, Mingfeng Yu, Shudong Wang
Discovery of Potent Inhibitors of Cyclin-Dependent Kinases 7 and 9: Design, Synthesis, Structure-Activity Relationship Analysis and Biological Evaluation. ChemMedChem (2022)
Mingfeng Yu, Yuchao Yang, Matthew J Sykes, Shudong Wang
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer. Journal of medicinal chemistry 65 (7) (2022)
Abel Tesfaye Anshabo, Laychiluh Bantie, Sarah Diab, Jimma Lenjisa, Alemwork Kebede, Yi Long, Gary K Heinemann, Jasmine Karanjia, Benjamin Noll, Sunita K C Basnet, Manjun Li, Robert Milne, Hugo Albrecht, Shudong Wang
An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia. Cancers 14 (5) (2022)
Saiful Islam, Shudong Wang, Nikola A Bowden, Jennifer H Martin, Richard J Head
Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target. British journal of clinical pharmacology (2021)
Ahmed M Abdelaziz, Mingfeng Yu, Shudong Wang
Mnk inhibitors: a patent review. Pharmaceutical patent analyst 10 (1) (2021)
Sarah Diab, Mingfeng Yu, Shudong Wang
CDK7 Inhibitors in Cancer Therapy: The Sweet Smell of Success? Journal of medicinal chemistry 63 (14) (2020)
Solomon Tadesse, Laychiluh Bantie, Khamis Tomusange, Mingfeng Yu, Saiful Islam, Nataliya Bykovska, Benjamin Noll, Ge Zhu, Peng Li, Frankie Lam, Malika Kumarasiri, Robert Milne, Shudong Wang
Discovery and pharmacological characterization of a novel series of highly selective inhibitors of cyclin-dependent kinases 4 and 6 as anticancer agents. British journal of pharmacology 175 (12) (2018)
Stephen Philip, Malika Kumarasiri, Theodosia Teo, Mingfeng Yu, Shudong Wang
Cyclin-Dependent Kinase 8: A New Hope in Targeted Cancer Therapy? Journal of medicinal chemistry 61 (12) (2018)
Muhammed H Rahaman, Yingyi Yu, Longjin Zhong, Julian Adams, Frankie Lam, Peng Li, Ben Noll, Robert Milne, Jun Peng, Shudong Wang
CDKI-73: an orally bioavailable and highly efficacious CDK9 inhibitor against acute myeloid leukemia. Investigational new drugs 37 (4) (2018)
Solomon Tadesse, Elizabeth C Caldon, Wayne Tilley, Shudong Wang
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. Journal of medicinal chemistry 62 (9) (2018)
Malika Kumarasiri, Theodosia Teo, Mingfeng Yu, Stephen Philip, Sunita K C Basnet, Hugo Albrecht, Matthew J Sykes, Peng Wang, Shudong Wang
In Search of Novel CDK8 Inhibitors by Virtual Screening. Journal of chemical information and modeling 57 (3) (2017)
Solomon Tadesse, Mingfeng Yu, Laychiluh B Mekonnen, Frankie Lam, Saiful Islam, Khamis Tomusange, Muhammed H Rahaman, Benjamin Noll, Sunita K C Basnet, Theodosia Teo, Hugo Albrecht, Robert Milne, Shudong Wang
Highly Potent, Selective, and Orally Bioavailable 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine Cyclin-Dependent Kinases 4 and 6 Inhibitors as Anticancer Drug Candidates: Design, Synthesis, and Evaluation. Journal of medicinal chemistry 60 (5) (2017)